AVIDITY BIOSCIENCES INC (RNA)

US05370A1088 - Common Stock

29.5  +0.78 (+2.72%)

After market: 29.38 -0.12 (-0.41%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-228.69M-212.22M-174.00M-118.01M-44.36M
Depreciation Amortization
2.35M2.10M1.39M640.00K370.00K
Change In Working Capital
58.44M64.11M9.82M5.34M2.33M
Interest Paid
N/AN/A0.000.00570.00K
Other non cash items
27.42M26.95M26.52M17.22M4.53M
OPERATING CASH FLOW
-140.47M-119.06M-136.27M-94.81M-37.12M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-3.32M-4.23M-2.82M-3.74M-1.09M
Other Investing Activity
36.19M-125.84M-187.13M-78.78M-6.69M
INVESTING CASH FLOW
32.86M-130.07M-189.96M-82.52M-7.79M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/AN/A0.000.00-4.68M
Stock Issued/Repurchased
190.51M62.67M346.17M187.58M300.75M
Other Financing Activity
N/A31.19MN/A-11.26M-24.03M
FINANCING CASH FLOW
460.35M93.86M346.17M176.32M272.04M
 
CHANGE IN CASH
352.74M-155.27M19.94M-1.01M227.13M
 
FREE CASH FLOW
Operating Cash Flow
-140.47M-119.06M-136.27M-94.81M-37.12M
Capital Expenditure
-3.32M-4.23M-2.82M-3.74M-1.09M
FREE CASH FLOW
-143.80M-123.29M-139.09M-98.55M-38.21M

All data in USD

Charts